How the Second mRNA Vaccine Bolsters Immunity
How the Second mRNA Vaccine Bolsters Immunity
A study looks beyond T and B cell responses to show how the Pfizer COVID-19 vaccine elicits a strong innate immune response.
How the Second mRNA Vaccine Bolsters Immunity
How the Second mRNA Vaccine Bolsters Immunity

A study looks beyond T and B cell responses to show how the Pfizer COVID-19 vaccine elicits a strong innate immune response.

A study looks beyond T and B cell responses to show how the Pfizer COVID-19 vaccine elicits a strong innate immune response.

COVID-19
Sodas, Lemon Juice Cause False Positives in Rapid COVID-19 Tests
Sodas, Lemon Juice Cause False Positives in Rapid COVID-19 Tests
Christie Wilcox | Jul 12, 2021
Lateral flow tests for COVID-19 can be very accurate and specific when used as directed, but introducing acidic fluids can cause the tests’ detecting antibodies to clump, which may read as a positive result.
Researchers Create Pathogen-Sensing Face Mask
Researchers Create Pathogen-Sensing Face Mask
Stephanie Melchor | Jul 5, 2021
The masks contain freeze-dried, cell-free biosensors, enabling them to detect pathogens including SARS-CoV-2.
Pandemic Lockdown Eases Mountain Lions’ Fear of Urban Areas
Pandemic Lockdown Eases Mountain Lions’ Fear of Urban Areas
Jef Akst | Jul 2, 2021
Six GPS-tracked wild cats wandered closer to Santa Cruz, California, and surrounding towns as human activity died down under shelter-in-place orders last March.
Opinion: Hunting a Changing Virus
Opinion: Hunting a Changing Virus
Libusha Kelly | Jul 1, 2021
A broad and nimble sequencing program is necessary to track, anticipate, and quash SARS-CoV-2 and other dangerous pathogens that threaten humanity.
Labs, Leaks, and Liability
Labs, Leaks, and Liability
Bob Grant | Jul 1, 2021
The resurfaced conversation surrounding the idea that SARS-CoV-2 might have leaked from a lab in Wuhan, China, represents an opportunity to reexamine the confluence of science, politics, and public discourse.
Ten Minute Sabbatical
Ten Minute Sabbatical
Emily Cox and Henry Rathvon | Jul 1, 2021
Take a break from the bench to puzzle and peruse.
The Researchers Who Pivoted to COVID-19: One Year On
The Researchers Who Pivoted to COVID-19: One Year On
Shawna Williams | Jul 1, 2021
The Scientist checks in on scientists who switched gears to combat the pandemic.
COVID-19 Vaccines Work in People with Cancer: Study
COVID-19 Vaccines Work in People with Cancer: Study
Marcus A. Banks | Jun 25, 2021
Moderna’s, Pfizer’s, and Johnson & Johnson’s shots all offered protection against the virus regardless of cancer type, although slightly less so in people with blood cancer.
Canadian Official Reprimanded for Withholding Winnipeg Lab Info
Canadian Official Reprimanded for Withholding Winnipeg Lab Info
Stephanie Melchor | Jun 23, 2021
The House of Commons rebuked the president of the Canadian Public Health Agency for not turning over sensitive information pertaining to the dismissal of government scientists from the National Microbiology Laboratory.
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Jef Akst | Jun 18, 2021
Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.
New Evidence Shows COVID-19 Was in US Weeks Before Thought
New Evidence Shows COVID-19 Was in US Weeks Before Thought
Abby Olena | Jun 17, 2021
Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.
Spike Protein Deletions Linked to COVID-19 Surges: Preprint
Spike Protein Deletions Linked to COVID-19 Surges: Preprint
Alejandra Manjarrez | Jun 15, 2021
Researchers find that surges in COVID-19 case numbers are associated with deletions in the SARS-CoV-2 genome in an antigenic site of the spike protein. Some of these mutations are present in vaccine breakthrough infections or reinfections.
Immune Cell Activity Mediates Severe COVID-19 Pathogenesis
Immune Cell Activity Mediates Severe COVID-19 Pathogenesis
The Scientist Creative Services Team in Collaboration with IsoPlexis | Jun 15, 2021
Functional profiling of immune cells uncovers targetable mechanisms underlying lung inflammation in severe COVID disease.
Glucometers Detect SARS-CoV-2 Infection Within an Hour
Glucometers Detect SARS-CoV-2 Infection Within an Hour
Roni Dengler, PhD | Jun 14, 2021
Glucometers are easy-to-use, cheap, and highly scalable. And they are 100 percent accurate at detecting SARS-CoV-2.
Inhaled Antibody Fragments Protect Infected Animals Against COVID-19
Inhaled Antibody Fragments Protect Infected Animals Against COVID-19
Roni Dengler, PhD | Jun 14, 2021
Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.
Skin Rash May Point to SARS-CoV-2 Infection
Skin Rash May Point to SARS-CoV-2 Infection
Roni Dengler, PhD | Jun 14, 2021
Skin symptoms are often the first, or only, symptom of COVID-19.
Scientific Breakthroughs with Cryogenic Electron Microscopy
Scientific Breakthroughs with Cryogenic Electron Microscopy
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | Jun 10, 2021
Structures made via cryo-EM give researchers insights into SARS-CoV-2, HIV, neurological disorders, cancer, and more.
Biosurveillance for Viral Infections
Biosurveillance for Viral Infections
The Creative Services Team in Collaboration with Tecan | Jun 8, 2021
Scientists use ELISAs to assess the immunity and etiology of immune responses to coronavirus during the COVID-19 pandemic.
SARS-CoV-2 Antigens Leaking from Gut to Blood Might Trigger MIS-C
SARS-CoV-2 Antigens Leaking from Gut to Blood Might Trigger MIS-C
Alejandra Manjarrez | Jun 3, 2021
Researchers find traces of SARS-CoV-2 in the stool and blood of kids with the post–COVID-19 inflammatory disorder, and signs of increased intestinal permeability.